Johnson & Johnson aims to have 100 million one-dose COVID-19 vaccines by spring – WFLA

TAMPA (WFLA) Johnson & Johnsonhopes to have enough COVID-19 vaccines for 100 million Americans by April as the government ramp up nationwide inoculation efforts, a company official says.

The drug maker is Going all out with its production while it awaits results from a large-scale clinical trial that could allow the shot to be approved for emergency use in the coming weeks, according to Dr. Mark McClellan who spoke to CNBC this week.

During remarks at the White House on Thursday, the governments top infectious disease doctor Anthony Fauci said that Johnson & Johnson would have enough data on its vaccine to begin analysis within a week or two.

ABOUT THE 3RD VACCINE

The Centers for Disease Control (CDC) reports that in the U.S. 10.6 million people have received the first dose of the Pfizer or Moderna vaccine. More than 39 million doses have been distributed as of January 22.

J&J expects to release data late this month from the Phase 3 trial of its single-dose coronavirus vaccine, which was shown togenerate an immune response to COVID-19in an early-stage study.

See more here:

Johnson & Johnson aims to have 100 million one-dose COVID-19 vaccines by spring - WFLA